Seçil Demirkol Canlı (Secil Demirkol-Canli, Secil Demirkol Canli, Secil Demirkol-Canlı, Seçil Demirkol Canli)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Biology

Turkish journal of medical sciences

Cancers

PloS one

Hacettepe University

Bilkent Üniversitesi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hacettepe University May 17 2018

Turkey

Post-doctoral researcher :: Molecular Pathology Application and Research Center

Bilkent University Feb 01 2018

Turkey

Postdoctoral Researcher :: Molecular Biology and Genetics

Education History

Bilkent Üniversitesi - Jan 02 2018

Turkey

PHD :: Molecular Biology and Genetics

Bilkent Üniversitesi

Turkey

BSC :: Molecular Biology and Genetics

Publications

Irena Barbara Padzińska-Pruszyńska, Muhammad Waqas Akbar, Murat Isbilen, Emilia Górka, Baris Kucukkaraduman, Seçil Demirkol Canlı, Ege Dedeoğlu, Shila Azizolli, Isli Cela, Abbas Guven Akcay, Haşim Hakanoğlu, Lubomir Bodnar, Szczepan Cierniak, Zygmunt Kozielec, Jacek Jerzy Pruszyński, Martyna Bittel, Ali Osmay Gure, Magdalena Król, Bartłomiej Taciak
Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues. International journal of molecular sciences 25 (11) (2024)
Irena Barbara Padzińska-Pruszyńska, Muhammad Waqas Akbar, Murat Isbilen, Emilia Górka, Baris Kucukkaraduman, Seçil Demirkol Canlı, Ege Dedeoğlu, Shila Azizolli, Isli Cela, Abbas Guven Akcay, Haşim Hakanoğlu, Lubomir Bodnar, Szczepan Cierniak, Zygmunt Kozielec, Jacek Jerzy Pruszyński, Martyna Bittel, Ali Osmay Gure, Magdalena Król, Bartłomiej Taciak
Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues. International journal of molecular sciences 25 (11) (2024)
Seçil Demirkol Canlı
CSRP1 expression is associated with a mesenchymal, stroma-rich tumor profile and poor prognosis in colon cancer. Turkish journal of medical sciences 53 (6) (2023)
Seçil Demirkol Canlı
CSRP1 expression is associated with a mesenchymal, stroma-rich tumor profile and poor prognosis in colon cancer. Turkish journal of medical sciences 53 (6) (2023)
Seçil Demirkol Canlı, Meral Uner, Baris Kucukkaraduman, Diren Arda Karaoglu, Aynur Isik, Nesrin Turhan, Aytekin Akyol, İsmail Gömcel, Ali Osmay Güre
A Novel Gene List Identifies Tumors with a Stromal-Mesenchymal Phenotype and Worse Prognosis in Gastric Cancer. Cancers 15 (11) (2023)
Seçil Demirkol Canlı
CSRP1 expression is associated with a mesenchymal, stroma-rich tumor profile and poor prognosis in colon cancer. Turkish journal of medical sciences 53 (6) (2023)
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Güre, Seçil Demirkol Canlı
Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. Biology 12 (2) (2023)
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Güre, Seçil Demirkol Canlı
Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. Biology 12 (2) (2023)
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Güre, Seçil Demirkol Canlı
Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. Biology 12 (2) (2023)
Meral Uner, Aynur Isik, Sıdıka Oztop, Erdem Karabulut, Seçil Demirkol Canlı, Aytekin Akyol
Gastric Carcinoma with Lymphoid Stroma: A Combination of Mismatch Repair Deficient Medullary Type and Epstein-Barr Virus-associated Gastric Carcinomas. International journal of surgical pathology 30 (6) (2022)
Inês Faleiro, Vânia Palma Roberto, Seçil Demirkol Canlı, Nicolas A Fraunhoffer, Juan Iovanna, Ali Osmay Güre, Wolfgang Link, Pedro Castelo-Branco
DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study. Cancers 13 (24) (2021)
Baris Kucukkaraduman, Ekin Gokce Cicek, Muhammad Waqas Akbar, Seçil Demirkol Canlı, Burcak Vural, Ali Osmay Güre
Epithelial-to-Mesenchymal Transition Is Not a Major Modulating Factor in the Cytotoxic Response to Natural Products in Cancer Cell Lines. Molecules (Basel, Switzerland) 26 (19) (2021)
Seyhan Turk, Can Turk, Muhammad Waqas Akbar, Baris Kucukkaraduman, Murat Isbilen, Seçil Demirkol Canlı, Umit Yavuz Malkan, Mufide Okay, Gulberk Ucar, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu, Ali Osmay Gure
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide. PloS one 15 (11) (2020)
Seçil Demirkol Canlı, Ege Dedeoğlu, Muhammad Waqas Akbar, Barış Küçükkaraduman, Murat İşbilen, Özge Şükrüoğlu Erdoğan, Seda Kılıç Erciyas, Hülya Yazıcı, Burçak Vural, Ali Osmay Güre
A novel 20-gene prognostic score in pancreatic adenocarcinoma. PloS one 15 (4) (2020)

Seçil Demirkol Canlı.css-eqlu8i{font-size:small;padding-left:4px;} (Secil Demirkol-Canli, Secil Demirkol Canli, Secil Demirkol-Canlı, Seçil Demirkol Canli)

Publication Activity (10 Years)

Top Topics

Top Venues

Seçil Demirkol Canlı (Secil Demirkol-Canli, Secil Demirkol Canli, Secil Demirkol-Canlı, Seçil Demirkol Canli)